Skip to main content

Table 6 Comparison of reduced eGFR, reduced eGFRDEGREE, and CKDuDEGREE prevalence and risk factors across DEGREE protocol studies

From: Prevalence and predictors of chronic kidney disease of undetermined causes (CKDu) in Western Kenya’s “sugar belt”: a cross-sectional study

First author and country/region

Total sample size

Reduced eGFR < 90

Proxy for CKD eGFR < 60

Reduced eGFRDEGREE < 90

CKDuDEGREE eGFR < 60

Associated risk factors with eGFR < 90 and < 60

Hamilton, et al. (2020). Malawi, southeast Africa

821

Did not report

Did not report

4.6% (95%CI 3.2, 6.3); n = 38

0.2% (95%CI 0.1, 0.9); n = 2

Increasing age, BMI

Ruiz-Alejos, et al. (2021). Northern Peru, Tumbes region

1,514 total sample; 1,272 after excluding those with DM, HTN, and HP

eGFR ≥ 60 to < 90: 16.6% (95%CI 14.8, 18.6)

1.7% (95%CI 1.1, 2.5); n = 26

eGFR ≥ 60 to < 90: 13%; n = 165

0.9% (95%CI 0.4, 1.5); n = 11

Low physical activity levels, kidney stones; sugarcane work was protective

Ruwanpathirana, et al. (2019). Anuradhapura, Sri Lanka

4,803 total sample; 3,351 after excluding those with DM, HTN, and HP

Did not report

12%; n = 576

Did not report

6.0% (95%CI 5.2, 6.8); n = 202

Advanced age, history of CKD among parents or siblings, living in areas classified as moderate and high CKDu-endemicity; agricultural work was not significant

O’Callaghan-Gordo, et al. (2019). Northern and Southern Indiaa

12,500

Did not report

Did not report

eGFR ≥ 60 to < 90: 17.0% (95%CI 16.0, 17.0); n = 2,125

Overall: 1.6% (95%CI 1.4, 1.9). Varied from 1.4% in northern urban areas to 4.8% southern rural

Older age, residence in a rural area, being male, and less formal education for each 5 years of school

Western Kenya, Muhoroni Sub-County

782

9.85% (95%CI 7.9, 12.2); n = 77

0.51% (95%CI 0.14, 1.3); n = 4

8.99% (95%CI 6.8, 11.5); n = 55

0.33% (95%CI 0.04, 1.2); n = 2

Sublocation, increasing age, non-normal BMI, HIV positivity

  1. DM diabetes mellitus, HTN hypertension, HP heavy proteinuria, BMI Body Mass Index, HIV Human Immunodeficiency Virus
  2. aData collected prospectively for other purposes but analyzed per DEGREE protocol